Freeze-dried engineered L. lactis expressing AMP HI reduced ETEC gut colonization, restored intestinal barrier, and suppressed inflammation in mice, demonstrating translational potential for engineered probiotic AMPs.
Living antibiotic factoryEngineered probiotic bacteria produce antimicrobial peptide directly in the gut, fighting infection where antibiotics often fail to reach
What the researchers found
L. lactis/HI: optimized freeze-drying (6% sorbitol), reduced ETEC colonization and LPS, restored tight junction genes, downregulated TNF-α/IL-1β/IL-6, upregulated IL-10 in ETEC-infected mouse intestine.
Why it matters
Oral AMP delivery via engineered probiotics solves the stability/delivery problem — the probiotic produces the antibiotic exactly where the infection is.
How the study worked
Engineering of L. lactis to express AMP HI, freeze-drying optimization with cryoprotectants, oral administration in ETEC-infected BALB/c mice, with colonization, LPS, tight junction, and cytokine assessment.
What this study cannot tell us
Mouse model. ETEC is one pathogen; activity against others not tested. Regulatory pathway for engineered probiotics complex.
How to read the evidence
Preclinical proof-of-concept with translational freeze-drying optimization. Novel engineered probiotic AMP approach.
When this study was published
Published in 2025.
The bigger picture
Engineered probiotics delivering AMPs could become a new class of oral anti-infectives that work locally in the gut without systemic side effects.
Questions still open
- Could engineered probiotic AMPs replace oral antibiotics for gut infections?
- How long does AMP expression persist after oral probiotic dosing?
- Would this approach work against C. difficile infection?
Common questions
What is an engineered probiotic AMP?
Is this better than regular antibiotics?
Read the original research
Engineered Lactococcus lactis expressing antimicrobial peptide HI: Enhanced survival and protection against ETEC in mice.
Journal of biotechnology, 410, 331-340
Citation
Hu, Mingyang; Bi, Chongpeng; Li, Yuwen; Xue, Yutong; Cha, Sina; Zhao, Lu; Xue, Chenyu; Dong, Na. (2026). Engineered Lactococcus lactis expressing antimicrobial peptide HI: Enhanced survival and protection against ETEC in mice.. Journal of biotechnology, 410, 331-340. https://doi.org/10.1016/j.jbiotec.2025.12.019